Hepatitis C Drug Therapy: Is There Still a Role for Hepatologists?

Content Type: presentation

Presenter: Paul Y. Kwo, MD, FACG

Presenter Disclosure: Advisory Committee/Board Member: AbbVie, Gilead Grant/Research Support: AbbVie, BMS, Gilead Data and Safety Monitoring Board: Janssen

Event: 2019 ACG Annual Postgraduate Course

Release Date: 3/10/2020

Expiration Date: 3/10/2023

Objective: Recognize the current state of hepatitis C therapy and the role of the hepatologist.